Safety and Efficacy of Cariprazine for Bipolar I Disorder
Open the official record
This page only displays public information reproduced from the official ClinicalTrials.gov record NCT01058668. It adds no medical advice, opinions, or eligibility judgments. The official record remains the source of truth for eligibility criteria, enrollment, and contact information.
All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Double-Blind, Placebo-Controlled, Evaluation of the Safety and Efficacy of Cariprazine in Patients With Acute Mania Associated With Bipolar I Disorder
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The objective of this study is to evaluate the efficacy, safety, and tolerability of cariprazine monotherapy versus placebo for the treatment of acute manic or mixed episodes associated with bipolar I disorder.
Study identification
- NCT ID
- NCT01058668
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 497 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 65 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Feb 2010 (Type not available)
- Primary completion
- Dec 2011 (Actual)
- Completion
- Dec 2011 (Actual)
- Last update posted
- Apr 12, 2017
2010 – 2011
United States locations
- U.S. sites
- 23
- U.S. states
- 17
- U.S. cities
- 22
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Forest Investigative Site 018 | Little Rock | Arkansas | 72211 | — |
| Forest Investigative Site 012 | Cerritos | California | 90703 | — |
| Forest Investigative Site 010 | Costa Mesa | California | 92626 | — |
| Forest Investigative Site 005 | Oceanside | California | 92056 | — |
| Forest Investigative Site 023 | San Diego | California | 92102 | — |
| Forest Investigative Site 017 | San Diego | California | 92103 | — |
| Forest Investigative Site 024 | Santa Ana | California | 92701 | — |
| Forest Investigative Site 016 | New Britain | Connecticut | 06050 | — |
| Forest Investigative Site 007 | Washington D.C. | District of Columbia | 20016 | — |
| Forest Investigative Site 002 | Kissimmee | Florida | 34741 | — |
| Forest Investigative Site 003 | Orlando | Florida | 32821 | — |
| Forest Investigative Site 026 | Atlanta | Georgia | 30308 | — |
| Forest Investigative Site 013 | Honolulu | Hawaii | 96813 | — |
| Forest Investigative Site 011 | Hoffman Estates | Illinois | 60169 | — |
| Forest Investigative Site 021 | Greenwood | Indiana | 46143 | — |
| Forest Investigative Site 001 | Shreveport | Louisiana | 71115 | — |
| Forest Investigative Site 006 | Rockville | Maryland | 20850 | — |
| Forest Investigative Site 025 | St Louis | Missouri | 63118 | — |
| Forest Investigative Site 008 | Cedarhurst | New York | 11516 | — |
| Forest Investigative Site 019 | Philadelphia | Pennsylvania | 19139 | — |
| Forest Investigative Site 015 | Memphis | Tennessee | 38119 | — |
| Forest Investigative Site 004 | Irving | Texas | 75062 | — |
| Forest Investigative Site 014 | Bothell | Washington | 98011 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 43 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01058668, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Apr 12, 2017 · Synced Nov 14, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.